Abstract
Carcinoma in the breast is a very common malignancies in women and very unusual in male although they are born with same breast cells and tissues. It starts growing in the cells of the acini, lacteferous duct, and lobules of the breast. The recent therapy available for the breast cancer treatment limits their use due to the resistance development toward a particular drug. Hence, an urge for overcoming such types of barriers, novel approaches is acquired in which nanocarrier is very important. The exterior of the nanosystems can be modified in such a way that help for drug targeting and controlled drug release over prolonged time period. Furthermore, multifunctional nanosystems for the treatment of drug-resistant breast cancer show possibility of inhibition of multidrug resistance, produce synergy among the chemotherapeutic agents without causing noticeable cytotoxicity with significant reduction in breast tumor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Multifunctional Theranostic Nanomedicines in Cancer
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
